Neuberger Berman Group
IRWD icon

Neuberger Berman Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Neuberger Berman Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.4K Sell
12,448
-62
-0.5% -$239 ﹤0.01% 2285
2026
Q1 		$43.9K Sell
12,510
-2,342
-16% -$9.6K ﹤0.01% 2120
2025
Q4 		$50.1K Buy
14,852
+4,610
+45% +$12K ﹤0.01% 2057
2025
Q3 		$13.4K Sell
10,242
-20,292
-66% -$21K ﹤0.01% 2024
2025
Q2 		$21.9K Buy
30,534
+19,566
+178% +$15.4K ﹤0.01% 2024
2025
Q1 		$16.1K Buy
10,968
+309
+3% +$736 ﹤0.01% 1947
2024
Q4 		$47.2K Buy
+10,659
New +$43.2K ﹤0.01% 1884

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group's IRWD Position: Q2 2026 in Review

Neuberger Berman Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 0.5% in Q2 2026, selling an estimated $239 and leaving 12,448 shares worth $52.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Neuberger Berman Group first reported a position in IRWD in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Neuberger Berman Group held 12,448 shares of Ironwood Pharmaceuticals worth $52.4K as of Q2 2026.
  • Neuberger Berman Group sold 62 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $239.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2285 holding.
  • Neuberger Berman Group first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.